3.4.17.11: glutamate carboxypeptidase
This is an abbreviated version!
For detailed information about glutamate carboxypeptidase, go to the full flat file.
Word Map on EC 3.4.17.11
-
3.4.17.11
-
methotrexate
-
prodrugs
-
high-dose
-
antibody-directed
-
leucovorin
-
hdmtx
-
methotrexate-induced
-
gene-directed
-
naaladase
-
gdept
-
antibody-enzyme
-
medicine
-
anti-cea
-
anti-carcinoembryonic
-
prodrug-activating
-
gcpii
-
2-pmpa
-
n-acetyl-aspartyl-glutamate
-
dampa
-
drug development
-
diagnostics
-
pharmacology
- 3.4.17.11
- methotrexate
-
prodrugs
-
high-dose
-
antibody-directed
- leucovorin
-
hdmtx
-
methotrexate-induced
-
gene-directed
- naaladase
-
gdept
-
antibody-enzyme
- medicine
-
anti-cea
-
anti-carcinoembryonic
-
prodrug-activating
- gcpii
- 2-pmpa
-
n-acetyl-aspartyl-glutamate
-
dampa
- drug development
- diagnostics
- pharmacology
Reaction
release of C-terminal glutamate residues from a wide range of N-acylating moieties, including peptidyl, aminoacyl, benzoyl, benzyloxycarbonyl, folyl and pteroyl groups =
Synonyms
carboxypeptidase G, carboxypeptidase G1, carboxypeptidase G2, CPDG2, CPG2, folate hydrolase G2, glucarpidase, glutamate carboxypeptidase, glutamyl carboxypeptidase, N-pteroyl-L-glutamate hydrolase, pteroylmonoglutamic acid hydrolase G2